SpringWorks Therapeutics, Inc. (SWTX) Costs and Expenses USD 2023 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
SpringWorks Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from 2023 to 2024.
  • SpringWorks Therapeutics, Inc. Costs and Expenses for the quarter ending March 31, 2024 was $115 M, a 47.9% increase year-over-year.
  • SpringWorks Therapeutics, Inc. annual Costs and Expenses for 2023 was $348 M, a 24.2% increase from 2022.
  • SpringWorks Therapeutics, Inc. annual Costs and Expenses for 2022 was $281 M, a 61.8% increase from 2021.
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $115 M +$37.2 M +47.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q1 2023 $77.7 M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.